These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 19390864)
21. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view. Edelson PJ Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171 [No Abstract] [Full Text] [Related]
22. Screening for genetic diseases. Motulsky AG N Engl J Med; 1997 May; 336(18):1314-6. PubMed ID: 9113938 [No Abstract] [Full Text] [Related]
23. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province]. Zhou YQ; Shang X; Yin BM; Xiong F; Xiao QZ; Zhou WJ; Zhang YL; Xu XM Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):90-5. PubMed ID: 22455738 [TBL] [Abstract][Full Text] [Related]
24. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Kaback MM Eur J Pediatr; 2000 Dec; 159 Suppl 3():S192-5. PubMed ID: 11216898 [TBL] [Abstract][Full Text] [Related]
25. Population-based carrier screening and prenatal diagnosis. Strom CM MLO Med Lab Obs; 2004 Aug; 36(8):12-7; quiz 20-1. PubMed ID: 15366363 [No Abstract] [Full Text] [Related]
26. Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan. Ghanei M; Adibi P; Movahedi M; Khami MA; Ghasemi RL; Azarm T; Zolfaghari B; Jamshidi HR; Sadri R Public Health; 1997 May; 111(3):153-6. PubMed ID: 9175458 [TBL] [Abstract][Full Text] [Related]
31. The ovrselling of genetic anxiety. Goodman MJ; Goodman LE Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291 [TBL] [Abstract][Full Text] [Related]
32. Variables that underlie cost efficacy of prenatal screening. Kinzler WL; Morrell K; Vintzileos AM Obstet Gynecol Clin North Am; 2002 Jun; 29(2):277-86, v-vi. PubMed ID: 12108828 [TBL] [Abstract][Full Text] [Related]
33. Tay-Sachs disease carrier screening: a model for prevention of genetic disease. Kaplan F Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools. Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919 [TBL] [Abstract][Full Text] [Related]
35. Carrier screening panels for Ashkenazi Jews: is more better? Leib JR; Gollust SE; Hull SC; Wilfond BS Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754 [TBL] [Abstract][Full Text] [Related]
36. Carrier screening for beta-thalassemia during pregnancy in India: a 7-year evaluation. Colah R; Surve R; Wadia M; Solanki P; Mayekar P; Thomas M; Gorakshakar A; Dastur A; Mohanty D Genet Test; 2008 Jun; 12(2):181-5. PubMed ID: 18439108 [TBL] [Abstract][Full Text] [Related]
37. Determinants of utilization of Tay-Sachs screening. Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954 [TBL] [Abstract][Full Text] [Related]
39. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia. Beard CA; Amor DJ; Di Pietro L; Archibald AD Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953 [TBL] [Abstract][Full Text] [Related]
40. Heredity insurance. Pines M N Y Times Mag; 1978 p 78+; 30 Apr 1978():. PubMed ID: 11663045 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]